Cartesian Growth II Closes $230M IPO

IPO

Cartesian Growth II wrapped up its initial public offering of 23 million units, including 3 million units through the exercise of the underwriters’ over-allotment option. The company’s sponsor is an affiliate of Cartesian Capital Group, LLC, a global private equity firm specializing in providing growth capital to transnational businesses.

Units list on the Nasdaq and trade under the ticker symbol RENEU. Each consists of one share and one-third of a warrant. Once the securities begin separate trading, shares and warrants will list under the ticker symbols RENE and RENEW.

Cartesian Growth II in its initial S-1 filing said it would focus on seeking high-growth businesses with proven or potential transnational operations or outlooks.

Cantor Fitzgerald was sole book-running manager for the offering and Piper Sandler & Co. was co-manager. Read more.

Total
0
Shares
Related Posts
IPO
Read More

Genesis Unicorn Capital Prices $75M IPO

Genesis Unicorn intends to focus its search on the intersection of the healthcare and technology industries, specifically within the biotechnology and pharmaceutical sectors.